CARDIAC GLYCOSIDES IN UP-TO-DATE CLINICAL PRACTICE

The article reviews the use of cardiac glycosides in patients with chronic heart failure, paroxysmal tachyarrhythmia and chronic atrial fibrillation (rate control). According to the recent studies results cardiac glycosides may be substituted by angiotensin-converting enzyme inhibitors, angiotensin...

Full description

Saved in:
Bibliographic Details
Published inAlʹmanakh klinicheskoĭ medit͡s︡iny no. 35; pp. 101 - 105
Main Authors Gurevich, M. A., Gavrilin, A. A.
Format Journal Article
LanguageEnglish
Russian
Published MONIKI 17.02.2016
Subjects
angiotensin-converting enzyme inhibitors
atrial fibrillation
cardiac glycosides
chronic heart failure
digoxin
esmolol
landiolol
verapamil
zofenopril
Online AccessGet full text

Cover

More Information
Summary:The article reviews the use of cardiac glycosides in patients with chronic heart failure, paroxysmal tachyarrhythmia and chronic atrial fibrillation (rate control). According to the recent studies results cardiac glycosides may be substituted by angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists, diuretics, calcium antagonists and beta-adrenoceptor blockers in order to decrease the risk of cardiac glycoside toxicity and, in some cases, to improve quality of life and prognosis of the patients.
ISSN:2072-0505
2587-9294
DOI:10.18786/2072-0505-2014-35-101-105